Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Challenges to demonstrating disease-modifying effects in Alzheimer's disease clinical trials.

Cummings JL.

Alzheimers Dement. 2006 Oct;2(4):263-71. doi: 10.1016/j.jalz.2006.07.001.

PMID:
19595897
2.

Optimal design of clinical trials for drugs designed to slow the course of Alzheimer's disease.

Mohs RC, Kawas C, Carrillo MC.

Alzheimers Dement. 2006 Jul;2(3):131-9. doi: 10.1016/j.jalz.2006.04.003.

PMID:
19595870
3.

Lowering the risk of Alzheimer's disease: evidence-based practices emerge from new research.

Jedrziewski MK, Lee VM, Trojanowski JQ.

Alzheimers Dement. 2005 Oct;1(2):152-60. doi: 10.1016/j.jalz.2005.09.007.

PMID:
19595848
4.

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism.

Rowe CC, Ackerman U, Browne W, Mulligan R, Pike KL, O'Keefe G, Tochon-Danguy H, Chan G, Berlangieri SU, Jones G, Dickinson-Rowe KL, Kung HP, Zhang W, Kung MP, Skovronsky D, Dyrks T, Holl G, Krause S, Friebe M, Lehman L, Lindemann S, Dinkelborg LM, Masters CL, Villemagne VL.

Lancet Neurol. 2008 Feb;7(2):129-35. doi: 10.1016/S1474-4422(08)70001-2. Epub 2008 Jan 10.

PMID:
18191617
5.

The effect of white matter lesions on cognition in the elderly--small but detectable.

Frisoni GB, Galluzzi S, Pantoni L, Filippi M.

Nat Clin Pract Neurol. 2007 Nov;3(11):620-7. Review.

PMID:
17982432
6.

Disease-modifying therapies for Alzheimer disease: challenges to early intervention.

Cummings JL, Doody R, Clark C.

Neurology. 2007 Oct 16;69(16):1622-34. Review.

PMID:
17938373
7.

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins.

Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K, Friedman LF, Galasko DR, Jutel M, Karydas A, Kaye JA, Leszek J, Miller BL, Minthon L, Quinn JF, Rabinovici GD, Robinson WH, Sabbagh MN, So YT, Sparks DL, Tabaton M, Tinklenberg J, Yesavage JA, Tibshirani R, Wyss-Coray T.

Nat Med. 2007 Nov;13(11):1359-62. Epub 2007 Oct 14.

PMID:
17934472
8.

Beta-amyloid burden is not associated with rates of brain atrophy.

Josephs KA, Whitwell JL, Ahmed Z, Shiung MM, Weigand SD, Knopman DS, Boeve BF, Parisi JE, Petersen RC, Dickson DW, Jack CR Jr.

Ann Neurol. 2008 Feb;63(2):204-12.

9.

Relationship of fMRI activation to clinical trial memory measures in Alzheimer disease.

Diamond EL, Miller S, Dickerson BC, Atri A, DePeau K, Fenstermacher E, Pihlajamäki M, Celone K, Salisbury S, Gregas M, Rentz D, Sperling RA.

Neurology. 2007 Sep 25;69(13):1331-41.

PMID:
17893294
10.

Prevalence of dementia subtypes in El Prat de Llobregat, Catalonia, Spain: the PRATICON study.

Gascón-Bayarri J, Reñé R, Del Barrio JL, De Pedro-Cuesta J, Ramón JM, Manubens JM, Sánchez C, Hernández M, Estela J, Juncadella M, Rubio FR.

Neuroepidemiology. 2007;28(4):224-34. Epub 2007 Sep 19.

PMID:
17878737
11.

What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?

Jagust W, Reed B, Mungas D, Ellis W, Decarli C.

Neurology. 2007 Aug 28;69(9):871-7.

PMID:
17724289
12.

Imaging of amyloid burden and distribution in cerebral amyloid angiopathy.

Johnson KA, Gregas M, Becker JA, Kinnecom C, Salat DH, Moran EK, Smith EE, Rosand J, Rentz DM, Klunk WE, Mathis CA, Price JC, Dekosky ST, Fischman AJ, Greenberg SM.

Ann Neurol. 2007 Sep;62(3):229-34.

PMID:
17683091
13.

Role of neuroimaging in Alzheimer's disease, with emphasis on brain perfusion SPECT.

Matsuda H.

J Nucl Med. 2007 Aug;48(8):1289-300. Epub 2007 Jul 13.

14.

Magnetic resonance imaging predictors of cognition in mild cognitive impairment.

van de Pol LA, Korf ES, van der Flier WM, Brashear HR, Fox NC, Barkhof F, Scheltens P.

Arch Neurol. 2007 Jul;64(7):1023-8.

PMID:
17620494
15.

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.

Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P.

Lancet Neurol. 2007 Aug;6(8):734-46. Review.

PMID:
17616482
16.

Acupuncture increases cerebral glucose metabolism in human vascular dementia.

Huang Y, Chen J, Htut WM, Lai X, Wik G.

Int J Neurosci. 2007 Jul;117(7):1029-37.

PMID:
17613112
17.

Olfactory identification and incidence of mild cognitive impairment in older age.

Wilson RS, Schneider JA, Arnold SE, Tang Y, Boyle PA, Bennett DA.

Arch Gen Psychiatry. 2007 Jul;64(7):802-8.

PMID:
17606814
18.

Longitudinal MRI and cognitive change in healthy elderly.

Kramer JH, Mungas D, Reed BR, Wetzel ME, Burnett MM, Miller BL, Weiner MW, Chui HC.

Neuropsychology. 2007 Jul;21(4):412-8.

19.

Structural correlates of apathy in Alzheimer's disease.

Apostolova LG, Akopyan GG, Partiali N, Steiner CA, Dutton RA, Hayashi KM, Dinov ID, Toga AW, Cummings JL, Thompson PM.

Dement Geriatr Cogn Disord. 2007;24(2):91-7. Epub 2007 Jun 14.

PMID:
17570907
20.

Morphological substrate of face matching in healthy ageing and mild cognitive impairment: a combined MRI-fMRI study.

Teipel SJ, Bokde AL, Born C, Meindl T, Reiser M, Möller HJ, Hampel H.

Brain. 2007 Jul;130(Pt 7):1745-58. Epub 2007 Jun 12.

PMID:
17566054

Supplemental Content

Support Center